Industry
Evidence workflows built for how your industry decides
Life sciences and public-sector teams do not share the same endpoints, regulators, or timelines—but they share the need for literature that can be inspected. LRN brings Explainable AI screening, human oversight, and audit-ready outputs to each setting.
One platform
Shared method, different stakes
Protocol framing, transparent include/exclude decisions, synthesis, and an AI Package Insert-style trail—configured to how your industry reports and reviews.
Explainable AI
Not a black-box summary
Every screening decision can leave linked terms, confidence signals, and human gates so Medical, Regulatory, and QA stakeholders can follow the same path.
Defensible speed
Faster without losing the trail
Compress months of manual review into focused days of work while retaining PRISMA-oriented structure and reproducible methods.
Explore
Choose where to go deeper
01
Pharmaceuticals & BioTech
Indication support, Medical Affairs narratives, HEOR inputs, and development landscapes—with trails that stand up in internal review.
Learn more
02
Medical Devices
Clinical evaluation and post-market literature for MDR/IVDR expectations—inspectable exclusions and standardized reporting.
Learn more
03
Clinical Research Organizations
Scale systematic and rapid reviews across sponsors with reusable protocols, human-in-the-loop gates, and defensible deliverables.
Learn more
04
Public Sector
Transparent syntheses for policy, guidance, and research programs—methods you can publish, share, and audit.
Learn more
Next step
Talk with us about LRN for your industry.